Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation
Clinical Genitourinary Cancer
· Elsevier
Аннотация
Publication date: December 2026 Source: Clinical Genitourinary Cancer, Volume 24, Issue 8 Author(s): Hiroki Sai, Hidetoshi Kuruma, Atsuya Okada, Yuki Enei, Takafumi Yanagisawa, Chieko Okazaki, Shusuke Akamatsu, Nat Lenzo, Kenta Miki, Takahiro Kimura
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Урология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation. // Clinical Genitourinary Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1558767326001655?dgcid=rss_sd_all
Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation. Clinical Genitourinary Cancer. https://www.sciencedirect.com/science/article/pii/S1558767326001655?dgcid=rss_sd_all
“Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation.” Clinical Genitourinary Cancer.
@article{article40875,
title = {Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation},
journal = {Clinical Genitourinary Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1558767326001655?dgcid=rss_sd_all}
}